ANO1 and cancer: Because the small-molecule inhibitors targeting ANO1 have been to date evaluated only in vitro, we investigated whether MCL1-mediated decrease of cancer cell viability is achievable by utilization of MCL1 inhibitor that is under clinical investigation.